Avid Bioservices Inc

NASDAQ:CDMO  
25.93
+0.33 (+1.29%)
Earnings Announcements

Avid Bioservices Q4 Revenue $27.6 Million

Published: 06/29/2021 20:20 GMT
Avid Bioservices Inc (CDMO) - Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments.
Q4 Revenue $27.6 Million.
Q4 Revenue Estimate $21.6 Million -- Refinitiv Ibes Data (analyst estimates).
Project Fiscal 2022 Revenue of $115 to $117 Million, Representing 20% - 22% Growth Over Fiscal 2021.
As of April 30, 2021, Revenue Backlog Was $118 Million, an Increase of 82% Compared to $65 Million at End of Last Fiscal Year.
Revenue is expected to be $27.81 Million
Adjusted EPS is expected to be $0.04

Next Quarter Revenue Guidance is expected to be $25.32 Million
Next Quarter EPS Guidance is expected to be $0.03

More details on our Analysts Page.